Vironova BioAnalytics

Vironova BioAnalytics is a Stockholm-based company founded in 2005 and is at the forefront of the biotechnology industry. The company's mission, as stated in its slogan, is to make the invisible visible today in order to build trust in the therapies of tomorrow. Vironova provides advanced electron microscopy analysis to support the global life science community in the development of novel therapies. The company offers a full-service value chain from initial sample preparation to final analytical results, empowering clients to make better-informed decisions and ensure patient safety. The company focuses on lowering technical thresholds and minimizing analytical complexity in gene therapy, vaccine, and drug development, thus targeting previously untreatable conditions. Vironova's dedication to technology and innovation is evident in its efforts to reduce time and cost to market for clients, ultimately creating value for patients worldwide. Notably, Vironova operates the world’s only GMP-certified TEM laboratory, providing fast and cost-effective electron microscopy services with reliable and traceable results. With over 200 established customer relationships, Vironova has proven itself as a leading partner for the life science industry. Additionally, the company boasts a strong acquisition pipeline of new clients and has made significant inroads within the global research community. Vironova's combination of industry expertise and data-driven insights enables clients to address real needs by making the subvisible accessible. Overall, Vironova BioAnalytics stands out as a dynamic and innovative player in the biotechnology space, offering valuable solutions to the global life science community.